• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对印度卫生技术评估生态系统的混合方法评估。

A Mixed-Methods Assessment of India's Health Technology Assessment Ecosystem.

作者信息

Chugh Yashika, Lakshmi Josyula K, Bahuguna Pankaj, Kaur Navneet, Jan Stephen, Prinja Shankar

机构信息

Department of Community Medicine and School of Public Health, Postgraduate Institute of Medical Education and Research (PGIMER), Sector-12, Chandigarh, 160 012, India.

The George Institute for Global Health, Hyderabad, Telangana, India.

出版信息

Appl Health Econ Health Policy. 2025 Sep 6. doi: 10.1007/s40258-025-00995-4.

DOI:10.1007/s40258-025-00995-4
PMID:40913689
Abstract

OBJECTIVE

This study aims to evaluate the technical quality of health technology assessment (HTA) studies conducted in India. Second, we aim to identify process-related challenges across the life cycle of an HTA from commissioning to policy translation.

METHODS

A mixed-methods approach was employed to assess HTA studies conducted between 2018 and 2023 conducted by ten regional resource centers. The quantitative assessment involved reviewing 26 HTA reports using the Indian HTA Quality Appraisal Checklist. The qualitative component included semi-structured interviews with staff from six regional resource centers and the Health Technology Assessment in India secretariat to explore the processes of topic selection, study conduct, stakeholder engagement, and evidence to policy translation. Quantitative data were analyzed through scoring and categorization into quality ratings, while qualitative data were analyzed thematically using the framework method.

RESULTS

In the quantitative assessment, 14% (n = 3) of studies were found to be of excellent quality, 50% (n = 11) were deemed to be of good quality, 32% (n = 7) were of average quality, and only one (4%) of poor quality. The qualitative findings highlighted limited adherence to guidelines, challenges in framing the topic, and gaps in technical expertise for advanced analyses. Additionally, a high staff turnover, the need for better stakeholder consultations, and strategies to disseminate the evidence were also highlighted.

CONCLUSIONS

These findings emphasize the need for improvements in adherence to guidelines, transparency in topic selection, and alignment of HTA findings with policy needs. Investments in training, advanced methodology guidance, and systematic communication between researchers and policy makers are crucial to enhancing HTA's impact in India.

摘要

目的

本研究旨在评估在印度开展的卫生技术评估(HTA)研究的技术质量。其次,我们旨在识别从委托开展到政策转化的HTA生命周期中与流程相关的挑战。

方法

采用混合方法评估2018年至2023年期间由十个区域资源中心开展的HTA研究。定量评估包括使用印度HTA质量评估清单对26份HTA报告进行审查。定性部分包括对六个区域资源中心的工作人员以及印度卫生技术评估秘书处进行半结构化访谈,以探讨主题选择、研究开展、利益相关者参与以及证据到政策转化的过程。定量数据通过评分和分类为质量等级进行分析,而定性数据则使用框架方法进行主题分析。

结果

在定量评估中,发现14%(n = 3)的研究质量优秀,50%(n = 11)被认为质量良好,32%(n = 7)质量中等,只有一项(4%)质量较差。定性研究结果突出了对指南的遵守有限、主题框架方面的挑战以及高级分析技术专长的差距。此外,还强调了员工流动率高、需要更好地与利益相关者进行协商以及传播证据的策略。

结论

这些发现强调了在遵守指南、主题选择的透明度以及使HTA结果与政策需求保持一致方面进行改进的必要性。在培训、先进方法指导以及研究人员与政策制定者之间的系统沟通方面进行投资对于增强HTA在印度的影响力至关重要。

相似文献

1
A Mixed-Methods Assessment of India's Health Technology Assessment Ecosystem.对印度卫生技术评估生态系统的混合方法评估。
Appl Health Econ Health Policy. 2025 Sep 6. doi: 10.1007/s40258-025-00995-4.
2
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
3
Remote and digital services in UK general practice 2021-2023: the Remote by Default 2 longitudinal qualitative study synopsis.2021 - 2023年英国全科医疗中的远程和数字服务:“默认远程”2纵向定性研究概要
Health Soc Care Deliv Res. 2025 Sep;13(31):1-49. doi: 10.3310/QQTT4411.
4
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
5
Accreditation through the eyes of nurse managers: an infinite staircase or a phenomenon that evaporates like water.护士长眼中的认证:是无尽的阶梯还是如流水般消逝的现象。
J Health Organ Manag. 2025 Jun 30. doi: 10.1108/JHOM-01-2025-0029.
6
Meeting the needs of women in the perinatal period, who use or are in treatment for using drugs: A mixed-methods systematic review.满足围产期使用毒品或正在接受戒毒治疗的妇女的需求:一项混合方法的系统评价。
Health Soc Care Deliv Res. 2025 Aug 20:1-25. doi: 10.3310/GJPR0321.
7
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
8
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验:定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.
9
Factors that influence participation in physical activity for people with bipolar disorder: a synthesis of qualitative evidence.影响双相障碍患者参与体育活动的因素:定性证据的综合分析。
Cochrane Database Syst Rev. 2024 Jun 4;6(6):CD013557. doi: 10.1002/14651858.CD013557.pub2.
10
How to Implement Digital Clinical Consultations in UK Maternity Care: the ARM@DA Realist Review.如何在英国产科护理中实施数字临床会诊:ARM@DA实证主义综述
Health Soc Care Deliv Res. 2025 May 21:1-77. doi: 10.3310/WQFV7425.

本文引用的文献

1
Establishing a Health Technology Assessment Evidence Ecosystem in India's Pradhan Mantri Jan Arogya Yojana.在印度的 Pradhan Mantri Jan Arogya Yojana 中建立健康技术评估证据生态系统。
Health Syst Reform. 2023 Dec 31;9(3):2327097. doi: 10.1080/23288604.2024.2327097. Epub 2024 May 7.
2
Health economic evaluations for Indonesia: a systematic review assessing evidence quality and adherence to the Indonesian Health Technology Assessment (HTA) Guideline.印度尼西亚的卫生经济评估:一项评估证据质量和对印度尼西亚卫生技术评估(HTA)指南遵循情况的系统评价
Lancet Reg Health Southeast Asia. 2023 Mar 31;13:100184. doi: 10.1016/j.lansea.2023.100184. eCollection 2023 Jun.
3
Protocol for estimating the willingness-to-pay-based value for a quality-adjusted life year to aid health technology assessment in India: a cross-sectional study.
用于评估印度卫生技术评估中质量调整生命年意愿支付价值的方案:一项横断面研究。
BMJ Open. 2023 Feb 16;13(2):e065591. doi: 10.1136/bmjopen-2022-065591.
4
Development of a Health Technology Assessment Quality Appraisal Checklist (HTA-QAC) for India.开发适用于印度的卫生技术评估质量评价清单(HTA-QAC)。
Appl Health Econ Health Policy. 2023 Jan;21(1):11-22. doi: 10.1007/s40258-022-00766-5. Epub 2022 Oct 19.
5
Challenges of Health Technology Assessment in Pluralistic Healthcare Systems: An ISPOR Council Report.多元化医疗体系中的卫生技术评估挑战:ISPOR 理事会报告。
Value Health. 2022 Aug;25(8):1257-1267. doi: 10.1016/j.jval.2022.02.006.
6
Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study: The Indian 5-Level Version EQ-5D Value Set.开发印度 EQ-5D 价值集的扩展设计(DEVINE)研究:印度 5 级版本 EQ-5D 价值集。
Value Health. 2022 Jul;25(7):1218-1226. doi: 10.1016/j.jval.2021.11.1370. Epub 2022 Jan 5.
7
Cost of Surgical Care at Public Sector District Hospitals in India: Implications for Universal Health Coverage and Publicly Financed Health Insurance Schemes.印度公立地区医院的外科护理成本:对全民健康覆盖和公共资助医疗保险计划的影响。
Pharmacoecon Open. 2022 Sep;6(5):745-756. doi: 10.1007/s41669-022-00342-6. Epub 2022 Jun 22.
8
Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force.设计和实施卫生技术评估的审议程序:HTAi/ISPOR 联合工作组的良好实践报告。
Int J Technol Assess Health Care. 2022 Jun 3;38(1):e37. doi: 10.1017/S0266462322000198.
9
Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries.卫生技术评估系统的异同及其对覆盖决策的影响:来自32个国家的证据
Pharmacoecon Open. 2022 May;6(3):315-328. doi: 10.1007/s41669-021-00311-5. Epub 2021 Nov 29.
10
Development of National Cancer Database for Cost and Quality of Life (CaDCQoL) in India: a protocol.印度国家癌症数据库成本和生活质量(CaDCQoL)的开发:方案。
BMJ Open. 2021 Jul 29;11(7):e048513. doi: 10.1136/bmjopen-2020-048513.